News | Peripheral Artery Disease (PAD) | May 14, 2018

SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease

Online resource will provide patient-centered information on PAD risk factors, therapies and patient education

SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease

May 14, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD Diagnosis and Treatment Resource Center. This center will be an ongoing, patient-centered quality improvement initiative focused on helping increase peripheral artery disease (PAD) awareness in the cardiovascular and internal medicine community by delving into the underlying risks of this disease state.

PAD impacts more than 10 million patients in the United States alone yet is woefully underdiagnosed. Lack of screening, underdiagnosis and undertreatment of PAD represent a critical gap in service to patients, as even asymptomatic PAD status is associated with the high long-term cardiovascular morbidity and mortality. Therefore, PAD has been targeted as one of SCAI’s key areas for quality improvement.

“I am excited to co-chair this important SCAI initiative on PAD awareness and education,” said Rajesh Swaminathan, M.D., FSCAI. “The condition is nearly as prevalent as CAD [coronary artery disease], yet still underdiagnosed. Early identification of PAD is key to proper counseling, risk factor modification and management to prevent future adverse clinical outcomes. The goal here is to provide PAD education, with incorporation of new clinical data in various formats, to inform and engage referring physicians, advanced practice providers, and fellows-in-training,” said Swaminathan.

The initiative also aims to improve the management and outcomes for PAD patients by providing a comprehensive review of “PAD 101.” This includes comprehensive discussions of:

  • Emerging data for secondary prevention in stable PAD;
  • Presentations to understand how to manage PAD patients; and
  • When to refer PAD patients for invasive therapies.

The multiyear program will be comprised of the following components:

  • The PAD Diagnosis and Treatment Resource Center: A five-part modular resource center hosted on SCAI’s website and packaged for easy download and dissemination; and
  • Webcast Series: A series of 30-minute webcasts based upon the PAD Diagnosis and Treatment Resource Center topics.

“The invasive therapy module will provide an evidence-based overview of the benefits of endovascular therapy and will help to clarify which patients should be considered for such therapy,” said Dmitriy Feldman, M.D., FSCAI, co-chair of the working group. “Furthermore, this module will focus on the SCAI-led Appropriate Use Criteria in EVT document as well as the newly released at SCAI 2018 Consensus Guidelines for Device Selection in Femoral-Popliteal Arterial Interventions.”

For more information: www.scai.org/padtoolkit

 

Related Content

News | Cardiac Diagnostics | June 14, 2018
A team of researchers says it has linked sensitivity to an allergen in red meat to the buildup of plaque in the...
The blood of patients with familial chylomicronemia syndrome (FCS) can appear milky in color (lipemic) due to the buildup of fat in their body. Image courtesy of Akcea Therapeutics.

The blood of patients with familial chylomicronemia syndrome (FCS) can appear milky in color (lipemic) due to the buildup of fat in their body. Image courtesy of Akcea Therapeutics.

 

Feature | Cardiac Diagnostics | May 07, 2018 | Steven D. Freedman, M.D., Ph.D.
 
Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Diagnostics | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
ERT Acquires iCardiac Technologies
News | Cardiac Diagnostics | December 19, 2017
ERT recently announced it has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory...
New Study Suggests Protein Could Protect Against Coronary Artery Disease

Patients with no obstructed blood flow in the coronary arteries had higher levels of CXCL5 (blue) compared to patients with moderate levels (green) or lower levels (yellow) of CXCL5, who had increased severity of coronary obstructions (indicated by the arrows). Credit: Schisler lab

News | Cardiac Diagnostics | December 07, 2017
December 7, 2017 — The buildup of plaque in the heart’s arteries is an unfortunate part of aging.
E-cigarettes Most Likely to be Used by Alcohol Drinkers and Former Cigarette Smokers, at American Heart Association (AHA), #AHA2017.
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Electronic cigarettes are more frequently used by people who recently quit smoking and alcohol dri
Lack of sleep may cause heart disease in older women. American heart Association, #AHA2017
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Older women who do not get enough sleep were more likely to have poor cardiovascular health, accor
New Tool Predicts Risk of Heart Attack in Older Surgery Patients
News | Cardiac Diagnostics | December 05, 2017
A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery...
Overlay Init